People
Sophie Binay
An immunology researcher and drug-development executive with previous R&D leadership at PEP-Therapy, InnaVirVax and Gustave Roussy. Acticor Biotech last publicly listed this person as General Manager and Chief Scientific Officer (historical, pre-liquidation). These affiliations precede the company’s January2025 judicial liquidation; current employment and exact role-end dates are unpublished.
Roles
Acticor Biotech
CurrentGeneral Manager and Chief Scientific Officer (historical, pre-liquidation)